Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Ellis

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Current Oncology (Toronto, Ont.)|March 9, 2017
Guideline for radiotherapy with curative intent in patients with early-stage medically inoperable non-small-cell lung cancerC B Falkson, E T Vella, E Yu, et al.
Current Oncology (Toronto, Ont.)|July 10, 2019
Initial management of small-cell lung cancer (limited- and extensive-stage) and the role of thoracic radiotherapy and first-line chemotherapy: a systematic reviewA Sun, L D Durocher-Allen, P M Ellis, et al.
Current Oncology (Toronto, Ont.)|July 10, 2019
Surgery after chemoradiotherapy in patients with stage III (N2 or N3, excluding T4) non-small-cell lung cancer: a systematic reviewA Swaminath, E T Vella, K Ramchandar, et al.
Medical Education|September 1, 1993
The oral examination: a study of academic and non-academic factorsC S Thomas, G Mellsop, K Callender, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1996
On the receiving end. V: Patient perceptions of the side effects of cancer chemotherapy in 1993A M Griffin, P N Butow, A S Coates, et al.
The Australian and New Zealand Journal of Psychiatry|September 1, 1994
Staffing and funding of consultation-liaison psychiatry services in Australia and New ZealandG C Smith, P M Ellis, V J Carr, et al.
Current Oncology (Toronto, Ont.)|February 21, 2009
The role of the epidermal growth factor receptor tyrosine kinase inhibitors as therapy for advanced, metastatic, and recurrent non-small-cell lung cancer: a Canadian national consensus statementP M Ellis, W Morzycki, B Melosky, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1997
Dimeric inhibins in amniotic fluid, maternal serum, and fetal serum in human pregnancyE M Wallace, S C Riley, J A Crossley, et al.
Prenatal Diagnosis|April 21, 1999
Clinical follow-up of high mid-trimester maternal serum intact human chorionic gonadotrophin concentrations in singleton pregnanciesG Blundell, J P Ashby, C Martin, et al.
Current Oncology (Toronto, Ont.)|September 25, 2019
An evaluation of the safety of continuing trastuzumab despite overt left ventricular dysfunctionC C Barron, M M Alhussein, U Kaur, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Current Oncology (Toronto, Ont.)|March 9, 2017
Guideline for radiotherapy with curative intent in patients with early-stage medically inoperable non-small-cell lung cancerC B Falkson, E T Vella, E Yu, et al.
Current Oncology (Toronto, Ont.)|July 10, 2019
Initial management of small-cell lung cancer (limited- and extensive-stage) and the role of thoracic radiotherapy and first-line chemotherapy: a systematic reviewA Sun, L D Durocher-Allen, P M Ellis, et al.
Current Oncology (Toronto, Ont.)|July 10, 2019
Surgery after chemoradiotherapy in patients with stage III (N2 or N3, excluding T4) non-small-cell lung cancer: a systematic reviewA Swaminath, E T Vella, K Ramchandar, et al.
Medical Education|September 1, 1993
The oral examination: a study of academic and non-academic factorsC S Thomas, G Mellsop, K Callender, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1996
On the receiving end. V: Patient perceptions of the side effects of cancer chemotherapy in 1993A M Griffin, P N Butow, A S Coates, et al.
The Australian and New Zealand Journal of Psychiatry|September 1, 1994
Staffing and funding of consultation-liaison psychiatry services in Australia and New ZealandG C Smith, P M Ellis, V J Carr, et al.
Current Oncology (Toronto, Ont.)|February 21, 2009
The role of the epidermal growth factor receptor tyrosine kinase inhibitors as therapy for advanced, metastatic, and recurrent non-small-cell lung cancer: a Canadian national consensus statementP M Ellis, W Morzycki, B Melosky, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1997
Dimeric inhibins in amniotic fluid, maternal serum, and fetal serum in human pregnancyE M Wallace, S C Riley, J A Crossley, et al.
Prenatal Diagnosis|April 21, 1999
Clinical follow-up of high mid-trimester maternal serum intact human chorionic gonadotrophin concentrations in singleton pregnanciesG Blundell, J P Ashby, C Martin, et al.
Current Oncology (Toronto, Ont.)|September 25, 2019
An evaluation of the safety of continuing trastuzumab despite overt left ventricular dysfunctionC C Barron, M M Alhussein, U Kaur, et al.
Pageof 10